SpineX, Inc., a clinical stage medtech company announced the groundbreaking results in its first human study in children with cerebral palsy. The study is published in the esteemed medical journal Nature Communications demonstrating unparalleled functional improvements with its proprietary non-surgical treatment SCiP TM (Spinal Cord Innovation in Pediatrics) in children with Cerebral Palsy (CP).
This study discusses how delivering non-invasive spinal neuromodulation, using SCiP TM , during Physical Therapy improved voluntary sensorimotor function in 16 out of 16 children over a wide range of ages and severities of CP. SpineX was awarded the Breakthrough Device Designation (BDD) from US FDA for SCiP and the proposed treatment of CP.
In addition, SpineX has engaged with FDA to gain alignment on a proposed clinical trial to be conducted in 2023; the results of which are anticipated to lead to FDA clearance of the SCiP TM device for the treatment of CP.
CP is severely debilitating with no current cure. Over 10,000 new cases are diagnosed each year where CP is the result of damage to the developing brain and describes a group of movement disorders that affect a person’s ability to move and maintain balance and posture.
To date there are no methods or medications to prevent or treat CP. Often children with CP are left to be treated with invasive surgeries that attempt to decrease spasticity, a common symptom of the disease.
SCiP TM is a non-invasive spinal electrical neuromodulation device which provides transcutaneous spinal cord neuro-stimulation to potentially treat the underlying neurological dysfunction in pediatric patients with CP.
SCiP TM aims to be the first medical device in the U.S. to treat CP by transforming the brain and spinal cord dysfunctional connectivity into highly functional systems.
“At just three years old and highly affected by CP, our son has shown such exciting progress since he began using SCiP,” said Dana, the mother of a young boy diagnosed with CP who was enrolled in a clinical study sponsored by SpineX. “We’re so grateful that our son was included in the clinical study with SCiP TM as it has opened up a world of possibilities for our son, and we hope others will be able to witness it soon.”
Spinal Neuromodulation is being developed as a platform technology by SpineX and SCiP TM represents their second Breakthrough Device Designation following the SCONE TM device which is in clinical trials for the treatment of Neurogenic Bladder.
https://www.nature.com/articles/s41467-022-33208-w
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fa-pilot-study-combining&filter=22
Treating children with cerebral palsy
- 1,412 views
- Added
Edited
Latest News
Which of the two DNA strand…
By newseditor
Posted 16 Jun
Microglia depletion prevent…
By newseditor
Posted 16 Jun
Colorectal cancer stem cell…
By newseditor
Posted 16 Jun
Paranoia in the brain
By newseditor
Posted 16 Jun
In-vitro 3D culture of func…
By newseditor
Posted 15 Jun
Other Top Stories
Does 'harsh parenting' lead to smaller brains?
Read more
Filters from tree branches to purify drinking water
Read more
How teeth sense the cold
Read more
Why the brain enjoys music
Read more
How brain encodes odor
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Pathways for macrophage upt…
By newseditor
Posted 16 Jun
Common and distinct neural…
By newseditor
Posted 16 Jun
Strand-resolved mutagenicit…
By newseditor
Posted 16 Jun
Innate-like T cells in live…
By newseditor
Posted 16 Jun
Membrane to cortex attachme…
By newseditor
Posted 16 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar